IL-6 is one of the central inflammatory cytokines in the pathogenesis of MM because it promotes neoplastic plasma cell proliferation and inhibits apoptosis.[25] Therefore, IL-6 signal suppression via an anti-IL-6 receptor antibody is essential in controlling plasma cell tumors. Here, IL6 is linked to Miyoshi myopathy.